AMRA: Facilitating precision medicine through accurate body mass analytics




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: AMRA: Facilitating precision medicine through accurate body mass analytics
Released on: November 04, 2015. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    AMRA (Advanced MR Analytics) are developing software that translates MRI scans into accurate fat and muscle measurements via a cloud-based service.
  • Summary
  • Transcript
  • Participants
  • Company
AMRA (Advanced MR Analytics) are developing software that translates MRI scans into accurate fat and muscle measurements via a cloud-based service. They have recently announced a major collaboration with Pfizer that will use their technology to assess the body composition of up to 7,000 subjects, and enable a deeper understanding of the relationship between fat distribution and metabolic health. Tommy Johansson, CEO of AMRA, talks to Fintan Walton about the software’s future applications as well as its value to physicians treating disease and pharmaceutical companies conducting clinical trials.
AMRA (Advanced MR Analytics) are developing software that translates MRI scans into accurate fat and muscle measurements via a cloud-based service. They have recently announced a major collaboration with Pfizer that will use their technology to assess the body composition of up to 7,000 subjects, and enable a deeper understanding of the relationship between fat distribution and metabolic health. Tommy Johansson, CEO of AMRA, talks to Fintan Walton about the software’s future applications as well as its value to physicians treating disease and pharmaceutical companies conducting clinical trials.
Tommy Johansson is AMRA’s Chief Executive Officer, with the responsibility for AMRA’s long-term strategy and day-to-day operation. Tommy’s background asserts an extensive history in both information technology and economics. Prior to AMRA, Tommy was the Co-Founder and CEO of C3 Technologies, one of the most successful start-up companies in Sweden’s history. In addition to his success with start-ups, Tommy worked previously as the Deputy CEO of IFS, Industrial and Financial Systems AB, an ERP software firm operating in 30+ countries. After beginning his career with Saab in 1980, he furthered his experience through a variety of positions within a number of large software companies, including Ericsson, Nokia, and ICL. Tommy earned his M.Sc. in Industrial Engineering and Management in Linköping, Sweden in 1980. He has also served as a part-time lecturer at Linköping University, within the Department for Production Economics.
AMRA is an international medical technology company, founded in 2010 as the first in the world to transform MR images into precise body composition measurements. Our Mission is to confront our global health challenges by establishing the foundation for body composition measurement and providing the knowledge to predict and prevent diseases. Our Vision is a new, fundamental way of thinking about health. We provide knowledge to the medical community so that every individual can become — and stay — healthy. AMRA collaborates with world-leading pharmaceutical organizations, biobanks, research institutions, and hospitals, aiding in the advancement of metabolic research and therapeutic application. With more accurate knowledge about our bodies, AMRA assists the world's medical leaders in predicting and preventing disease. The company, headquartered in Sweden, is a spin-off of Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT), and the Department of Medicine and Health (IMH) at Linköping University, Sweden.